Similase
Similase, licence 80108826: active licence in Health Canada data. The French and European references below do not constitute authorisation for sale in France or an assessment of safety or efficacy.
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
Natural health product licensed in Canada
- Licence holder
- Nature's Way of Canada Ltd.
- NPN or DIN-HM
- 80108826
- Status
- Active licence
- Licence date
- 21 March 2021
- Revision date
- Not provided
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Protéase Source : Aspergillus flavus var. oryzae - En entier | 63.872 mg | Not calculated |
| Protéase Source : Aspergillus flavus var. oryzae - En entier | 35082.0 FCC HUT | Not calculated |
| Protéase Source : Aspergillus niger - En entier | 63.872 mg | Not calculated |
| Protéase Source : Aspergillus niger - En entier | 35082.0 FCC HUT | Not calculated |
| bêta-galactosidase Source : Aspergillus flavus var. oryzae - En entier | 800.0 FCC ALU | Not calculated |
| bêta-galactosidase Source : Aspergillus flavus var. oryzae - En entier | 7.041 mg | Not calculated |
| myo-Inositol-hexakisphosphate 3-phosphohydrolase Source : Aspergillus niger - En entier | 0.082 mg | Not calculated |
| myo-Inositol-hexakisphosphate 3-phosphohydrolase Source : Aspergillus niger - En entier | 0.85 FCC FTU | Not calculated |
Non-medicinal ingredients
Inuline, Stéarate de magnésium, Maltodextrine, Cellulose microcristalline, Fructooligosaccharides, Hydroxypropyl méthylcellulose, Dextrine
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 19.0 Année(s) | 2.0 Capsule | minimum: 2.0 Tous les jours ; maximum: 3.0 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Digestive aid. Digestive aid to help digest proteins. Digestive enzyme that helps digest proteins. Digestive enzyme/lactase to assist in the digestion of foods containing lactose (e.g. dairy foods, milk). Digestive enzyme. Helps prevent symptoms of lactose intolerance (including gas, bloating, cramping and diarrhea).
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80108826
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.